Immunic (IMUX) Depreciation and Depletion (2018 - 2024)

Immunic (IMUX) reported Depreciation and Depletion of $42000.0 for Q3 2024, up 23.53% on a YoY basis from $34000.0 in Q4 2023, and up 35.48% sequentially from $31000.0 in Q2 2024.

Immunic (IMUX) Depreciation and Depletion (2018 - 2024) Analysis & Trends

Immunic (IMUX) has 7 years of Depreciation and Depletion data on file, last reported at $42000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Immunic 11.03 Mn 11.03 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 42,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 31,000.00
Jun 30, 2024 31,000.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00
Sep 30, 2023 34,000.00
Sep 30, 2023 34,000.00
Jun 30, 2023 22,000.00
Jun 30, 2023 22,000.00
Mar 31, 2023 32,000.00
Mar 31, 2023 32,000.00
Sep 30, 2022 17,000.00
Sep 30, 2022 17,000.00
Jun 30, 2022 20,000.00
Jun 30, 2022 20,000.00
Mar 31, 2022 32,000.00
Mar 31, 2022 32,000.00
Sep 30, 2021 17,000.00
Sep 30, 2021 17,000.00